|
|
|
|
| Advertisement |
 |
|
|
| Advertisement |
Seizing Opportunities in Japan, the Second Largest Innovation-Driven Pharmaceutical Market
Tuesday, October 23, 2018 at 6pm EDT
 Register Now
|
|
| Advertisement |
A panel discussion with insights from emerging biopharma executives
On Demand
 Learn More
|
|
|
| Calendar |
|
/ November 6–7: Independent Expert Committees / |
|
Amsterdam, The Netherlands |
|
/ November 14–15: Commercial Data Insights 2018 / |
|
Philadelphia, PA |
|
/ November 14–15: 5th Annual Global Compliance Congress for Life Sciences / |
|
London, UK |
|
/ November 28–29: Compliant Patient Support Programs Summit / |
|
Chicago, IL |
|
/ December 4–5: Managed Markets Compliance Congress
2018
/ |
|
Philadelphia, PA |
|
/ December 12: Specialty Product Data Strategies
/ |
|
Philadelphia, PA |
|
/ January 22–23, 2019: 14th Biosimilars Summit
/ |
|
Alexandria, VA |
|
/ January 23–24, 2019: Data Analytics and Decisions
/ |
|
Philadelphia, PA |
|
/ March 4–6, 2019: 20th Annual Patient Assistance and Access Programs – PAP 2019
/ |
|
Baltimore, MD |
|
|
|
|
|
|
| US |
 |
|
How Fast are the FDA Fast Lanes? |
There's been a lot of talk about speeding up drug approval at FDA. Leela Barham takes a look at the speed of approval for each of FDA's expedited development and review methods
… /Read more/ |
|
|
| Advertisement |
Leverage Your Data to Meet Rising Expectations within Life Sciences
On Demand
 Learn More
|
|
|
| Industry update |
| //
The Mundipharma network of independent associated companies confirmed the appointment of Philippe Bastide as Head of Biosimilars, Mint Commercial, reporting to Chris Surridge, European Director of Strategy and Commercial Excellence.
//
Merus (Utrecht, The Netherlands) announced updates to its management team. Hui Liu, Ph.D., Executive Vice President and Chief Business Officer, will assume additional responsibilities as Head of Merus U.S. Peter B. Silverman, J.D., was appointed as Executive Vice President and General Counsel. Jillian Connell joined Merus as Vice President of Investor Relations and Corporate Communications.
//
Vifor Pharma (Bern, Switzerland) announced changes to its management. Barbara Angehrn joined the Executive Committee in the newly created position of Chief Business Officer, effective November 1. Scott Garland will step down as President of Relypsa to pursue new opportunities in the biotech sector. Patrick Treanor has assumed the role on an interim basis.
//
AMRA Medical (Linköping, Sweden) appointed Eric Converse as its new Chief Executive Officer//
Recipharm (Stockholm, Sweden) appointed Tobias Hägglöv as Chief Financial Officer.
|
|
|
